Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 387.51K P/E - EPS this Y - Ern Qtrly Grth -
Income -907.32k Forward P/E - EPS next Y - 50D Avg Chg -
Sales 4.04M PEG - EPS past 5Y - 200D Avg Chg -
Dividend N/A Price/Book 0.00 EPS next 5Y - 52W High Chg -
Recommedations - Quick Ratio 0.34 Shares Outstanding 15.50M 52W Low Chg -
Insider Own - ROA -10.27% Shares Float - Beta 0.22
Inst Own - ROE - Shares Shorted/Prior -/- Price 0.00010
Gross Margin 39.92% Profit Margin -22.45% Avg. Volume 1,641 Target Price -
Oper. Margin -4.99% Earnings Date - Volume 5,620 Change 0.00%
About HEMAGEN DIAGNOSTICS INC

Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its human diagnostics products also comprise Universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company provides veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. It sells its products directly, as well as through distributors to various laboratories, hospitals, and blood banks. The company was founded in 1985 and is based in Columbia, Maryland.